Sell Facebook Thesis

by Ross Kesselman ’21 and Rory Nizolek ’19 The SIF currently owns 75 shares of Facebook (FB) and it makes up 2% of the portfolio. Although the company has grown its profitability and has a relatively low beta of .62 over the past 3 months, the ongoing...

Gilead Pitch

by Ross Kesselman ’21 Gilead Pharmaceuticals, a biopharmaceutical company, discovers, develops and commercializes therapeutics in the areas of unmet medical needs in the United States, Europe, and internationally. Gilead pharmaceuticals is an attractive...
Skip to toolbar